WuXi AppTec acquires US-based CRO noting recent Chinese regulatory reforms

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/psisa)
(Image: Getty/psisa)

Related tags Wuxi apptec Clinical trial

WuXi AppTec’s acquisition of ResearchPoint Global (RPG) follows the release of a new guideline that will enable Chinese companies to accept clinical trial data from other countries.

The guideline was issued last week​ in a move to reform the management of clinical trials in the country.

WuXi cited the recent regulatory changes in its announcement of the acquisition, noting the opportunities presented by the reform.

According to the company, the acquisition is a strategic step forward to expand its clinical research capabilities in the US and globally.

The Austin, Texas-headquartered contract clinical research organization will operate as a wholly-owned subsidiary of WuXi. WuXi’s China-based Clinical Development Service (CDS) team will be integrated into the new business unit.

Dr. Ge Li WuXi AppTec chairman and CEO commented in a press release: "This business combination lays the groundwork for the creation of an integrated global clinical service organization with global expertise and global network."

Related news

Show more

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars